Financing Strategies to Facilitate Access to High-Cost Anticancer Drugs: A Systematic Review of the Literature.

Patikorn, Chanthawat; Taychakhoonavudh, Suthira; Sakulbumrungsil, Rungpetch; Ross-Degnan, Dennis; Anantachoti, Puree

Patikorn, Chanthawat; Taychakhoonavudh, Suthira; Sakulbumrungsil, Rungpetch; Ross-Degnan, Dennis; Anantachoti, Puree.

Afiliação

Patikorn C; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Taychakhoonavudh S; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Sakulbumrungsil R; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Ross-Degnan D; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Landmark Center, Boston, MA, USA.
Anantachoti P; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.

Int J Health Policy Manag ; 11(9): 1625-1634, 2022 09 01.

Article em En | MEDLINE | ID: mdl-34814670

Assuntos

Antineoplásicos; Custos de Medicamentos; Humanos; Antineoplásicos/uso terapêutico; Custos e Análise de Custo

Palavras-chave

Antineoplastic Drug; Expensive; Reimbursement

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Antineoplásicos Tipo de estudo: Health_economic_evaluation / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google